Tradeable Listing Approval for Baite Biotech Group

Stock symbol approval for: JXCN
September 23, 2019
DCSX confirms Yellow Maple as a Listing Advisor
September 25, 2019

Tradeable Listing Approval for Baite Biotech Group

DCSX has approved the listing of 200,000,000 shares, (of which 40,000,000 Shares are directly trade-able, and the remaining 160,000,000 Shares being directly trade-able only at such time as is approved by DCSX) of Baite Biotech Group Limited (DCSX Symbol BTSW).  Biztrack Consultants is the mandated Listing Advisor.

Baite Biotech Group Limited was incorporated in the British Virgin Islands on 20 March 2019 as the listing (holding) entity of the Operating Company for its proposed listing on DCSX. The Operating Company is a company registered in China with an operating track record of more than 20 years. The Group is based in Nanchang City in Jiangxi Province, China.

The principal businesses of the Group consist of two business segments. The first business segment is the manufacture and sales of IVD products which comprises diagnostic instruments and reagents needed to carry out diagnostic tests using these instruments. The second business segment is the provision of intelligent clinical laboratory solutions which comprises project design and construction of clinical laboratories and supply and installation of IVD products to these clinical laboratories.

The company listed on the DCSX for the following reasons:

(a) allow Shareholders – more specifically holders of Trade-able Shares – who may wish to trade their shares through a stock exchange to do so;

(b) broaden the Company’s shareholder base;

(c) facilitate the Group to raise further capital when such additional capital is required to expand the Group’s business operations or for such other purposes as they may arise; and

(d) make the Company a more attractive investment target to suppliers, customers, and other strategic partners because the Company accepts and submits itself to the regulations under the Listing Rules, particularly on issues such as continual disclosures and corporate governance. This will allow for these other stakeholders to take equity stakes in the Company so that their interests are aligned with those of the Company and the Group.

Further details about the business will be found on our Markets page on this website under Equities Symbol BTSW, section Company Information.

Comments are closed.

Local Time
FUCG  $0.09PGFL-CW  $100CSKG  $0.30CORDG-UK  £0.05AURE-PA  $1,000CAPRM-UK  $0.15SDEC  $1,000ECOPL-UK  €1.80ENTA  $0.50HUWH-MO  $0.12JMYS  $0.14KHGJ  $0.40OFRT365  $1.39RLYD  $0.11YIMA  $0.30WSYS  $0.70UPXS  $0.10ZAXX-SA  €1MDSF-V9  $1,000NGRF-V9-A  $1,000NGRF-V9-B  $1,000KQGJ  $0.50YSAF-V9  $1,000CDSE  $0.21HHCN  $0.20LGHL  $1PHAG  SFr.250SDTL  $1UMSC  $0.73BDMS1-CW  ƒ100EOMN-CW  ƒ100CHFU-CW  ƒ100BDCB-CW  ƒ100GBIF  $1,000KYJT  $0.26HTGP  $0.66BITA-CW  $0.18PROAM-UK  £0.01FIDII-PA  $1JGIF  $2,000ZGHGF-KY  $102 1/2% CW 2010/2020   $113.702 3/4% CW 2010/2025   $123.552 7/8% CW 2010/2030   $130.933% CW 2010/2035  $139.38 3 1/8% CW 2010/2040   $148.102 3/4% CW 2013/2043  $140.68ZGKY  $0.60BTSW  $0.28BTGJ  $0.38JNCY  $1CNCB  $0.50ECCN  $0.88RGIF  $1,000JXCN  $0.61
   
DCSX EVENTS